Opus Genetics
IRD
28 hedge funds and large institutions have $1.78M invested in Opus Genetics in 2019 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 10 increasing their positions, 4 reducing their positions, and 5 closing their positions.
150% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 4
3% less funds holding
Funds holding: 29 → 28 (-1)
20% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 5
57% less capital invested
Capital invested by funds: $4.16M → $1.78M (-$2.39M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$355K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$145K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$119K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$47.9K |
| 5 |
BlackRock
New York
|
+$16.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$1.44M |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$565K |
| 3 |
Jane Street
New York
|
-$12K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.29K |
| 5 |
SF
Synovus Financial
Columbus,
Georgia
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AFM
26
Anson Funds Management
Dallas,
Texas
| – | -$565K | -12,648 | Closed |
|
|
27
Jane Street
New York
| – | -$12K | -277 | Closed |
|
|
SF
28
Synovus Financial
Columbus,
Georgia
| – | -$1K | -21 | Closed |
|
|
VCM
29
Vigilant Capital Management
Portland,
Maine
| – | -$1K | -17 | Closed |
|
|
CAGAS
30
Capital Advisory Group Advisory Services
Bloomington,
Minnesota
| – | -$265 | -8 | -42% |
|
31
Wells Fargo
San Francisco,
California
| – | -$265 | -8 | -67% |
|
IRD Hedge Fund Activity: Q1 2019 in Review
28 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Opus Genetics (IRD) for Q1 2019, worth a combined $1.78M — down 57% from $4.16M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of IRD and 4 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 10 added.
The largest buyer was Renaissance Technologies, adding an estimated $355K. The largest seller was CVI Holdings, exiting entirely with an estimated $1.44M sold.
- 28 institutional investors held Opus Genetics (IRD) as of Q1 2019, down from 29 in Q4 2018.
- Funds reported $1.78M of Opus Genetics stock for Q1 2019, down 57% quarter-over-quarter.
- 4 funds opened new Opus Genetics positions in Q1 2019 and 5 closed out, a net change of -1 holder.
- The largest Opus Genetics buyer in Q1 2019 was Renaissance Technologies, an estimated $355K added.
- The largest Opus Genetics seller in Q1 2019 was CVI Holdings, an estimated $1.44M sold.
Based on aggregated 13F filings for Q1 2019.